Anticorps Recombinant de lapin anti-Angiotensinogen/AGT

Angiotensinogen/AGT Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

rat, souris

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

250570F8

N° de cat : 86134-1-PBS

Synonymes

Agt, Serpina8



Informations sur le produit

86134-1-PBS cible Angiotensinogen/AGT dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons rat, souris

Réactivité rat, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Angiotensinogen/AGT Protéine recombinante Eg2763
Nom complet angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
Masse moléculaire calculée52 kDa
Poids moléculaire observé52-55 kDa
Numéro d’acquisition GenBankN/A
Symbole du gène Agt
Identification du gène (NCBI) 11606
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Angiotensinogen is a precursor of angiotensin II (Ang II), is expressed and synthesized largely in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. It has a key role in mediating vascular constriction and regulating salt and fluid homeostasis. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.

{{ptg:RelatedPrimaryAntibodies}}